Clinical Trials in Maryland

Showing 6641-6660 of 23,284 trials

A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

NCT06555822

The main purpose of this study is to assess the safety, tolerability, and pharmacokinetic (PK) of AZD5004 administered as multiple oral doses in healthy participants and to compare the relative bioavailability of two oral tablet strengths of AZD5004.

Healthy Participants

AstraZeneca31 participantsStarted Aug 2024

Brooklyn, Maryland, United States

COMPLETED17 miles

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

NCT03718546

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Quality of Life

Center for International Blood and Marrow Transplant Research754 participantsStarted Apr 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Duarte, California, United States +28 more locations

A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Find Trials by Condition in Maryland

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)

A Study of LY3561774 in Participants With Mixed Dyslipidemia

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

IMPROVE AKI Cluster-Randomized Trial

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure